REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 218 filers reported holding REATA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,216,266 | +198.0% | 24,376 | +24.5% | 0.01% | +300.0% |
| Q4 2022 | $743,616 | +38.0% | 19,574 | +10.4% | 0.00% | +100.0% |
| Q2 2022 | $539,000 | -8.0% | 17,725 | +194.7% | 0.00% | -50.0% |
| Q3 2020 | $586,000 | +2690.5% | 6,015 | +4019.9% | 0.00% | – |
| Q1 2020 | $21,000 | -94.3% | 146 | -91.9% | 0.00% | -100.0% |
| Q4 2019 | $371,000 | +1586.4% | 1,813 | +574.0% | 0.00% | – |
| Q3 2019 | $22,000 | -46.3% | 269 | -38.6% | 0.00% | – |
| Q2 2019 | $41,000 | +10.8% | 438 | 0.0% | 0.00% | – |
| Q1 2019 | $37,000 | +1750.0% | 438 | +338.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
| Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
| Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
| Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
| Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
| KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
| Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
| MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
| Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |